Navigation Links
Eliminating Cellulite

WALTHAM, Mass., Millennium Research Group (MRG) has conducted a detailed analysis of the US aesthetics lasers market in its US Markets for Aesthetics Lasers and Energy Devices 2007 report. The analysis reveals that over the next five years more women will be receiving cellulite reduction procedures as noninvasive cellulite reduction products receive over- the-counter FDA approvals. In 2006, 330,000 people in the US received laser and energy device assisted cellulite reduction procedures, and by 2011 that number will more than double.

While most aesthetic laser procedures require some level of physician supervision or intervention, a number of noninvasive cellulite reduction devices will gain over the counter approval by the FDA. Over the counter cellulite reduction devices will be readily adopted in spas because they garner significantly higher overall profit margins versus most spa based procedures.

"Although cellulite occurs in individuals of varying weights, cellulite severity is correlated with increased weight. In the US, the average weight is increasing annually, particularly in younger generations, thereby expanding the population pool for cellulite reduction treatment," says Jaya Classen, senior analyst at MRG. "The expanding patient pool combined with increasing awareness and acceptance of medical cellulite reduction procedures, will drive growth in this market through 2011 and beyond."

The US Markets for Aesthetics Lasers and Energy Devices 2007 report includes coverage of key industry competitors, including Candela Corporation, Lumenis, Palomar Medical Technologies, Cutera, Alma Lasers, Syneron, and Reliant.

About Cellulite

Cellulite is the collection of fat pockets that give the skin a dimpling, orange peel-like appearance. Cellulite occurs more frequently in women than men because cellulite is associated with increased estrogen levels; the most common areas affected are the abdomen, thighs, and buttocks.

Nearly 90% of women over the age of 16 experience some degree of cellulite, and although its severity is correlated with obesity, cellulite can occur in an individual of any weight.


'"/>




Related medicine news :

1. Eliminating Eye Infection With Antibiotics
2. Eliminating Eye Infection With Antibiotics
3. India Targets Eliminating Leprosy
4. Palatal Implant Procedure Proven Effective in Eliminating Snoring
5. Period Eliminating Pills
6. New Gene Therapy may Be Helpful in Eliminating Arthritis Pain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... MLM Insurance Group, a Miami ... southern Florida, is working to support the Take Stock In Children Foundation during ... families. , The Take Stock In Children Foundation (TSC) offers guidance and assistance ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... of highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, ... hormone imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: A ... a couple that grew stronger together through the faith they shared to overcome struggles ... is the creation of published author, Barbara J. Corcoran, a retired teacher and happily ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... of high-quality anti-aging skincare solutions, recently announced the launch of two ... are an affordable, yet effective alternative to expensive plastic surgery or in-patient cosmetic ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... is adding a new location in Goldsboro, NC to its family of practices. ... is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene Associates Family ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... Fenita J. Caldwell is ... Lifetime Professional in the Field of Healthcare. Caldwell ... Pharmaceuticals, AG. Her skills and areas of expertise ... Fenita ... experience as a highly successful sales specialist in ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
Breaking Medicine Technology: